- RNA processing and alternative splicing are essential molecular mechanisms that transform newly synthesized RNA transcripts into mature, functional RNA molecules. These processes regulate gene expression, increase transcript diversity, and allow organisms to produce different RNA and protein products from the same gene. In eukaryotic cells, RNA processing includes several modifications, such as 5′ capping, intron removal, exon joining, and 3′-end cleavage and polyadenylation. Alternative splicing further increases molecular diversity by allowing different combinations of exons to be included in mature messenger RNA (mRNA). These mechanisms are fundamental to molecular biology, genetics, transcriptomics, functional genomics, and bioinformatics.
- In eukaryotes, protein-coding genes are transcribed primarily by RNA polymerase II to produce precursor messenger RNA (pre-mRNA), also called primary transcript. This initial transcript contains both exons and introns. Exons are regions retained in mature RNA, while introns are generally removed during RNA splicing. The pre-mRNA also contains untranslated regions (UTRs), which are important for regulating mRNA stability, localization, and translation. Before the transcript becomes a mature mRNA molecule, it undergoes several processing events that influence its stability, transport, translation efficiency, and biological function.
- One of the earliest processing events is the addition of a 5′ cap to the newly synthesized pre-mRNA. This structure consists of a modified guanine nucleotide, known as 7-methylguanosine, connected to the RNA through an unusual 5′–5′ triphosphate linkage. The 5′ cap protects the RNA from degradation by exonucleases and supports several important molecular processes. It helps recruit proteins involved in RNA processing, promotes the export of mature mRNA from the nucleus, and facilitates translation initiation by allowing recognition by the eukaryotic translation machinery. Cap-associated proteins also contribute to the coordination of transcription and RNA processing.
- RNA splicing is the process through which introns are removed from pre-mRNA and neighbouring exons are joined together. In most eukaryotic protein-coding genes, splicing is carried out by the spliceosome, a large ribonucleoprotein complex containing small nuclear RNAs (snRNAs) and associated proteins. The major spliceosome contains five principal small nuclear ribonucleoprotein particles (snRNPs): U1, U2, U4, U5, and U6. These components recognize important sequences in the pre-mRNA and coordinate the chemical reactions required for intron removal. Most introns contain characteristic splice-site signals, including a 5′ splice site, a branch-point sequence containing an important adenine nucleotide, and a 3′ splice site. During splicing, the intron forms a lariat structure through two sequential transesterification reactions. The intron is released, and the neighbouring exons are joined to form a continuous RNA sequence.
- In addition to the major spliceosome, some organisms contain a minor spliceosome that removes a smaller group of rare introns. These introns are commonly called U12-type introns and are processed by a distinct set of small nuclear ribonucleoproteins. Although less common than major spliceosome-dependent splicing, minor introns are found in genes involved in important cellular processes. Defects in either major or minor splicing pathways can disrupt normal gene expression and contribute to developmental disorders and disease.
- The 3′ end of most eukaryotic mRNAs is formed through cleavage and polyadenylation. During this process, the pre-mRNA is cleaved at a specific site, and a chain of adenine nucleotides known as the poly(A) tail is added by poly(A) polymerase. The poly(A) tail interacts with poly(A)-binding proteins and contributes to mRNA stability, nuclear export, and translation efficiency. The cleavage and polyadenylation machinery recognizes sequence elements in the pre-mRNA, including the commonly occurring AAUAAA signal or related variants. The length and regulation of the poly(A) tail can influence how long an mRNA remains available for translation. Some transcripts also undergo alternative polyadenylation, producing different 3′ ends and potentially changing their regulatory properties.
- Alternative splicing is a process in which different combinations of exons from the same pre-mRNA are joined to generate multiple mature RNA transcripts. This mechanism allows a single gene to produce several transcript isoforms and, in many cases, different protein isoforms. Alternative splicing greatly expands the functional diversity of eukaryotic genomes without requiring a corresponding increase in the number of genes. It is particularly important in multicellular organisms, where different tissues and cell types require distinct protein forms to perform specialized functions.
- Several major types of alternative splicing have been identified. Exon skipping, also called cassette exon splicing, occurs when an exon is either included in or excluded from the mature transcript. Alternative 5′ splice-site selection changes the beginning of an exon, while alternative 3′ splice-site selection changes its end. Intron retention occurs when an intron remains in the mature transcript instead of being completely removed. Mutually exclusive exon splicing allows one of two alternative exons to be included, but usually not both. These patterns can alter protein-coding sequences, introduce premature termination codons, change protein domains, or modify untranslated regions that regulate RNA stability and translation.
- Alternative splicing is controlled by interactions between cis-regulatory elements in pre-mRNA and trans-acting regulatory proteins. Cis-regulatory elements include exonic splicing enhancers, exonic splicing silencers, intronic splicing enhancers, and intronic splicing silencers. These sequences influence the recruitment or activity of spliceosomal components. Trans-acting factors include serine/arginine-rich proteins (SR proteins) and heterogeneous nuclear ribonucleoproteins (hnRNPs), which can promote or inhibit the use of particular splice sites. Other RNA-binding proteins and regulatory molecules also influence splicing decisions. The combination of these regulatory elements determines which exons are included in mature transcripts.
- Alternative splicing is influenced by tissue type, developmental stage, cellular signals, environmental conditions, and physiological state. For example, different transcript isoforms may be produced in the brain, muscle, liver, and reproductive tissues. During development, changes in splicing patterns can regulate cell differentiation and the formation of specialized tissues. In response to environmental stress, cells may alter the splicing of genes involved in metabolism, immunity, cell survival, and stress signalling. These changes allow organisms to adjust protein function and gene expression according to biological requirements.
- Alternative splicing can also influence disease development. Mutations in splice sites, branch-point sequences, or regulatory regions may cause abnormal intron retention, exon skipping, or the use of incorrect splice sites. Such changes can disrupt protein structure, introduce premature stop codons, or reduce the amount of functional protein produced. Abnormal splicing is associated with several diseases, including cancer, neurological disorders, muscular dystrophies, and inherited genetic conditions. In cancer, altered expression or activity of splicing factors can generate transcript isoforms that promote cell proliferation, survival, invasion, and treatment resistance. Some disease-causing variants do not directly change the amino acid sequence of a protein but instead alter how the corresponding pre-mRNA is processed.
- RNA processing and alternative splicing are also connected to other mechanisms of gene regulation. Transcription speed can influence splice-site selection because RNA processing often occurs while transcription is still taking place. Chromatin structure, histone modifications, DNA methylation, and transcription factors can affect the recruitment of splicing regulators. RNA editing and chemical modifications, including N6-methyladenosine (m6A), can also influence RNA processing and splicing decisions. Furthermore, alternative splicing can interact with nonsense-mediated decay (NMD), a quality-control pathway that degrades many transcripts containing premature termination codons. This relationship allows cells to regulate gene expression by controlling both transcript processing and transcript stability.
- RNA processing and alternative splicing are investigated using several experimental methods. Reverse-transcription PCR (RT-PCR) can identify different transcript isoforms by amplifying regions that contain alternative exons. Quantitative RT-PCR (RT-qPCR) can measure the relative abundance of selected isoforms. RNA sequencing (RNA-seq) provides genome-wide information about transcript abundance, exon usage, intron retention, and alternative splicing events. Long-read sequencing technologies, including Oxford Nanopore and PacBio sequencing, can identify full-length transcripts and help resolve complex combinations of alternative exons. Other approaches, such as RNA immunoprecipitation (RIP-seq) and cross-linking immunoprecipitation sequencing (CLIP-seq), can identify interactions between RNA molecules and splicing regulatory proteins.
- Bioinformatics plays a central role in analysing RNA processing and alternative splicing. A typical RNA-seq workflow begins with sequencing quality assessment, adapter removal, read alignment, transcript quantification, and splicing analysis. FastQC and MultiQC are commonly used for quality control, while fastp and Cutadapt support read preprocessing. STAR and HISAT2 are widely used for alignment to reference genomes. StringTie supports transcript reconstruction, while Salmon and Kallisto can estimate transcript abundance. Tools such as rMATS, MAJIQ, SUPPA2, and DEXSeq are used to identify and quantify different types of alternative splicing events. LeafCutter detects differential intron usage, while IsoformSwitchAnalyzeR helps investigate changes in transcript isoform usage and their potential functional consequences.
- Differential splicing analysis compares transcript-processing patterns between biological conditions, such as healthy and diseased tissues, different developmental stages, or different animal breeds. Researchers examine changes in exon inclusion, intron retention, splice-site selection, and transcript isoform abundance. Percent spliced in (PSI), also called the percent spliced-in value, is a commonly used measure that estimates the proportion of transcripts containing a particular alternative exon or splicing event. Statistical methods are required to determine whether observed differences are significant, and multiple-testing correction is important when analysing thousands of genes and splicing events. Visualization tools such as IGV, sashimi plots, and splice-junction diagrams help researchers inspect the supporting sequencing evidence.
- Alternative splicing has important applications in medicine, agriculture, biotechnology, and animal breeding. In medicine, identifying disease-associated transcript isoforms can improve the understanding of disease mechanisms and support the development of diagnostic biomarkers and targeted therapies. Some therapeutic approaches aim to modify splicing using antisense oligonucleotides that promote or suppress the inclusion of selected exons. In animal breeding, alternative splicing may contribute to variation in muscle development, growth, fat deposition, milk production, reproduction, immune responses, and environmental adaptation. Different transcript isoforms can influence the structure and activity of proteins involved in economically important traits. Comparing splicing patterns among breeds, tissues, developmental stages, and environmental conditions can therefore provide additional information about the molecular basis of animal performance.
- Despite its importance, the analysis of RNA processing and alternative splicing presents several challenges. Short-read sequencing may identify individual splice junctions but can have difficulty reconstructing complete transcript isoforms, especially when genes contain many exons or complex splicing patterns. Low-abundance transcripts and rare splicing events may be difficult to detect. Differences in RNA quality, sequencing depth, library preparation, reference genome quality, and computational pipelines can also affect results. Furthermore, detecting an alternative splicing event does not automatically establish its biological function or effect on protein production. Long-read sequencing, targeted experimental validation, and integration with proteomic and functional data can help address these limitations.
- Overall, RNA processing and alternative splicing are essential mechanisms that increase transcript diversity and regulate gene expression. Through 5′ capping, splicing, 3′-end processing, and alternative exon selection, cells produce mature RNA molecules with different structures, stability, and functional properties. These processes contribute to cellular differentiation, development, disease mechanisms, and biological adaptation. Bioinformatics provides powerful methods for analysing transcript isoforms, identifying splicing events, and investigating their functional consequences, making RNA processing and alternative splicing important areas of modern genomics and computational biology.